Skip to research content
Back to companies
BIOMERIEUX logo

BIOMERIEUX

France · AMF public disclosuresFR0013280286

Last 12 months

Reported buys

Not available

Reported sales

Not available

Net buy/sell balance

Not available

Other reported value

Not available

Total reported value

Not available

Public filings

Not available

Price and filing history

Price history and filing amounts shown for context.

Insider trades and share price

Monthly insider activity over issuer price. Circle color shows the buy/sale net, size shows total reported value, dashed outlines show value reported outside buy/sale classifications, and halos mark hybrid-significant operations.

Insider filing data is still loading. Historical price data is still loading.

Loading chart data

Insider activity and price evolution

Signals Pro

Price change after the observation · 1, 3 and 6 months

Net buying
1 month: +0.8%
3 months: +2.9%
6 months: +6.1%
Net selling
1 month: -1.2%
3 months: -2.6%
6 months: -3.8%

Illustrative example with simulated data. These results do not describe this company.

What follows months of insider activity?

Compare monthly net buying and selling with subsequent price movements. Signals Pro quantifies the observed relationship and shows how much evidence supports it.

  • Rank association at the same month and after 1, 3 and 6 months
  • Median price changes after net buying and net selling
  • Sample sizes and evidence levels, without implying causality
Explore Signals Pro

Public filings

Open any row to inspect the regulatory record and its transactions.

Sell

Gross reported (EUR)

€129,616,844.86

Evidence
Supporting information

SOFINA SA société anonyme

personne morale liée à Harold Boël, Administrateur de BIOMÉRIEUX S.A.

InitialEffective

Buy/sale net: -€129,616,844.86

Buy

Gross reported (EUR)

€54,544,968.11

Evidence
Supporting information

INSTITUT MERIEUX

personne morale liée à Alexandre Mérieux, Président du Conseil d'administration

InitialEffective

Buy/sale net: €54,544,968.11

Buy

Gross reported (EUR)

€29,099,866.79

Evidence
Supporting information

INSTITUT MERIEUX

personne morale liée à Alexandre Mérieux, Président du Conseil d'administration

InitialEffective

Buy/sale net: €29,099,866.79

Buy

Gross reported (EUR)

€29,099,866.79

Evidence
Supporting information

INSTITUT MERIEUX

personne morale liée à Alexandre Mérieux, Président du Conseil d'administration

InitialEffective

Buy/sale net: €29,099,866.79

Buy

Gross reported (EUR)

€54,544,968.11

Evidence
Supporting information

INSTITUT MERIEUX

personne morale liée à Alexandre Mérieux, Président du Conseil d'administration

InitialEffective

Buy/sale net: €54,544,968.11

Sell

Gross reported (EUR)

€263,317.34

Evidence
Supporting information

YASHA MITROTTI VENTURA

Directeur Exécutif

InitialEffective

Buy/sale net: -€263,317.34

Sell

Gross reported (EUR)

€170,199.90

Evidence
Supporting information

CELINE MARTIN ROGER DALBERT

Directrice Exécutive

InitialEffective

Buy/sale net: -€170,199.90

Yasha MITROTTI

25 Jul 2025
Buy

Gross reported (EUR)

€15,061.76

Evidence
Supporting information

Yasha MITROTTI

Executive Vice President, Industrial Applications

InitialEffective

Buy/sale net: €15,061.76

Sell

Gross reported (EUR)

€299,370.00

Evidence
Supporting information

GUILLAUME BOUHOURS

Directeur Exécutif

InitialEffective

Buy/sale net: -€299,370.00

Pierre BOULUD

11 Mar 2025
Sell

Gross reported (EUR)

€673,419.30

Evidence
Supporting information

Pierre BOULUD

Directeur Général

InitialEffective

Buy/sale net: -€673,419.30

Sell

Gross reported (EUR)

€179,951.32

Evidence
Supporting information

YASHA MITROTTI VENTURA

Executive Vice President

InitialEffective

Buy/sale net: -€179,951.32

MARK MILLER

6 Sept 2023
Sell

Gross reported (EUR)

€150,482.14

Evidence
Supporting information

MARK MILLER

Directeur Exécutif Affaires Médicales

InitialEffective

Buy/sale net: -€150,482.14

Sell

Gross reported (EUR)

€171,897.28

Evidence
Supporting information

YASHA MITROTTI VENTURA

Directeur Exécutif

InitialEffective

Buy/sale net: -€171,897.28

Insider timing in this issuer

Explore the full ranking

Each row is recomputed using this issuer's episodes. This is not a company accuracy score.

Pro access required

Current Signals, proprietary rankings and advanced research require an entitled Pro account. Public filings and available regulatory history remain free.

See what Pro includes

Online checkout is not available yet. Access shown here reflects your current account permissions.

Network and insiders

Explore verified connections and select an insider to inspect their role and evidence.

Explore relationship network

Evidence

Open a filing in the activity ledger to inspect its transactions, original regulatory document and source provenance.

Activity

Identify the affected field and a source that supports the correction. Use the private contact for rights requests; do not attach identity documents unless necessary and requested.

How to cite this record

OpenInsider. “BIOMERIEUX”. Record issuer:fr:amf:549300AK8Y0LBIQ4T071. https://openinsider.eu/en/companies/issuer%3Afr%3Aamf%3A549300AK8Y0LBIQ4T071 Regulatory source: AMF. The official publication remains authoritative.

Profiles and figures may change with new filings and corrections. Record the period and access date when reusing a figure; this link is not a historical snapshot.